Kinnevik: Deltagande i nyemission i Millicom International Cellular S.A.
November 30, 2004 02:10 ET
|
Kinnevik
Investment AB Kinnevik ("Kinnevik") meddelade idag att man till fullo stödjer den nyemission som Millicom International Cellular S.A. ("Millicom") annonserade tidigare idag. Kinnevik äger cirka 35% av...
Graham Dixon joins Galapagos as Chief Scientific Officer
November 30, 2004 02:06 ET
|
Crucell N.V.
MECHELEN, Belgium and LEIDEN, The Netherlands, Nov. 30, 2004 (PRIMEZONE) -- Galapagos announced today that Graham Dixon has been appointed Chief Scientific Officer (CSO). Dr. Dixon will be...
AB Volvo Repurchase 250,000 B shares
November 30, 2004 02:05 ET
|
Volvo
GOTEBORG, Sweden, Nov. 30, 2004 (PRIMEZONE) -- Further to the decision taken by AB Volvo's Board of Directors on June 17, 2004, regarding repurchase of own shares, AB Volvo has, on Monday, November...
Graham Dixon joins Galapagos as Chief Scientific Officer
November 30, 2004 02:00 ET
|
Galapagos NV
About Galapagos Genomics NVGalapagos is a genomics based drug discovery company with programs in osteoporosis, rheumatoid arthritis, osteoarthritis, Alzheimer's disease and asthma. Proprietary...
Following EMEA decision to review safety of COX-2 class, Novartis temporarily withdraws EU Mutual Recognition Procedure application for Prexige®
November 30, 2004 01:30 ET
|
Novartis Pharma AG
Basel, November 30, 2004 - Novartis Pharma AG announced today that it has withdrawn the application for the EU Mutual Recognition Procedure for Prexige® (lumiracoxib) to await the outcome of the...
Following EMEA decision to review safety of COX-2 class, Novartis temporarily withdraws EU Mutual Recognition Procedure application for Prexige(R)
November 30, 2004 01:30 ET
|
Novartis
BASEL, Switzerland, Nov. 30, 2004 (PRIMEZONE) -- Novartis Pharma AG announced today that it has withdrawn the application for the EU Mutual Recognition Procedure for Prexige(R) (lumiracoxib) to await...
*MERGING OF 2000 B OPTION RIGHTS OF VAISALA CORPORATION
November 30, 2004 01:00 ET
|
Vaisala Oyj
EXCHANGE NOTICE 475 /2004, 30 November 2004 OPTION RIGHTS
A total of 468 000 Vaisala Corporation's 2000 B option rights, attached to the Vaisala Corporation's warrant
program 2000,...
*VAISALA OYJ:N VUODEN 2000 B-OPTIO-OIKEUKSIEN YHDISTELY
November 30, 2004 01:00 ET
|
Vaisala Oyj
TIEDOTE 475/2004, 30.11.2004 OPTIO-OIKEUDET
Vaisala Oyj:n vuoden 2000 optio-ohjelman B-optio-oikeudet yhteensä 468.000 kappaletta ovat kaupankäynnin kohteena yhdessä listattujen...
Feintool Group achieves turnaround and posts much-improved results
November 30, 2004 01:00 ET
|
Feintool International Holding AG
After two years of falling results, all three segments posted strong sales and earnings growth. In particular, EBIT increased by CHF 13.3 million following the write-back in the last financial year of...
- July 26, 2024 17:00 ET Premier American Uranium Outlines Multiple Targets for Expansion Drilling at the Cebolleta Project, New Mexico
- July 26, 2024 16:30 ET Arhaus Unveils Showroom in Palo Alto, California